Intelligence Hub
Market analytics and operational performance indicators
144 - March 14, 2025
RKLB officer Arjun Kampani files Form 144 to sell 28,836 shares (~$524K) from RSU vesting.
Brief
Rocket Lab officer Arjun Kampani filed Form 144 on 2025-03-14 notifying proposed sale of 28,836 common shares (7,740 + 21,096) valued at ~$524,276 via Morgan Stanley. Shares stem from restricted stock units vesting on 2025-03-15 as compensation, with portion for tax obligations. Routine insider transaction with no prior sales in past 3 months; relevant for tracking executive liquidity.
Detailed Brief
Form 144 discloses officer Arjun Kampani's intent to sell 28,836 shares of Rocket Lab USA Inc. (RKLB) common stock on or about 2025-03-14 on NASDAQ, brokered by Morgan Stanley Smith Barney LLC. Breakdown: 7,740 shares ($140,723) and 21,096 shares ($383,553), against 506M shares outstanding. Securities acquired via RSU vesting on 2025-03-13 (13,787 + 38,685 units) as issuer compensation. Sale covers vested equity award taxes; no sales reported in prior 3 months. Kampani certifies no undisclosed material adverse information, aligning with Rule 144 for affiliates selling restricted securities post-holding period.
Key Telemetry
- • Arjun Kampani (Officer) to sell 28,836 common shares totaling ~$524,276.
- • Shares from RSU vesting on 2025-03-13: 13,787 + 38,685 units acquired as compensation.
- • Sale on 2025-03-14 includes tax withholding; no prior 3-month sales.
- • ~0.006% of 506M outstanding shares; broker Morgan Stanley.
Impact Vector
Routine post-vesting sale by RKLB officer, primarily for taxes, poses negligible dilution risk (0.006% of shares outstanding). Certifies no material adverse info, signaling confidence. Near-term: minimal stock pressure; strategically neutral for space launch firm. Monitor future Forms 144 or 4s for insider selling patterns amid RKLB's growth trajectory.